Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Azenta Inc AZTA

Azenta, Inc. is a provider of biological and chemical compound sample exploration and management solutions for the life sciences industry. The Company’s segments include Sample Management Solutions, Multiomics and B Medical Systems. The Sample Management Solutions segment offers end-to-end sample management products and services, including sample and repository services and core products... see more

Recent & Breaking News (NDAQ:AZTA)

Flex Set to Join S&P MidCap 400; Azenta and Concentra Group Holdings to Join S&P SmallCap 600

PR Newswire 3 days ago

Azenta to Participate in Stephens Annual Investment Conference

PR Newswire 8 days ago

Azenta Reports Fourth Quarter and Full Year Fiscal 2024 Results; Announces the Plan to Sell B Medical Systems and Appoints Lawrence Y. Lin as CFO

PR Newswire 10 days ago

Azenta Announces Fiscal 2024 Fourth Quarter and Full Year Earnings Conference Call and Webcast

PR Newswire November 4, 2024

Azenta Announces the Addition of Three New Independent Directors Effective Immediately and New Initiative to Drive Value

PR Newswire November 4, 2024

Azenta Obtains Regulatory Approval for Clinical Long-Read Whole Genome Sequencing Test

PR Newswire October 30, 2024

AZENTA ANNOUNCES APPOINTMENT OF JOHN P. MAROTTA AS CEO

PR Newswire September 4, 2024

GENEWIZ from Azenta Life Sciences Celebrates 25 Years of Advancing Scientific Discoveries at GENEWIZ Week Event

PR Newswire August 12, 2024

Azenta Reports Third Quarter Results for Fiscal 2024, Ended June 30, 2024

PR Newswire August 6, 2024

Azenta to Participate in 9th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference

PR Newswire August 5, 2024

Azenta Announces Fiscal 2024 Third Quarter Earnings Conference Call and Webcast

PR Newswire July 24, 2024

FinnGen Selects Azenta to Propel Personalized Medicine for Population Health Study

PR Newswire July 22, 2024

Azenta Announces Collaboration with the Crohn's & Colitis Foundation to Support its Crohn's Disease and Ulcerative Colitis Clinical Research

PR Newswire June 4, 2024

Azenta to Participate in the Jefferies Global Healthcare Conference

PR Newswire May 23, 2024

Azenta Opens the Doors to Its New Genomics Laboratory in Oxford, UK

PR Newswire May 13, 2024

Azenta Announces CEO Succession Plan

PR Newswire May 8, 2024

Azenta Reports Second Quarter Results for Fiscal 2024, Ended March 31, 2024

PR Newswire May 8, 2024

Azenta Announces Fiscal 2024 Second Quarter Earnings Conference Call and Webcast

PR Newswire May 1, 2024

Azenta Publishes its 2023 Environmental, Social, & Governance (ESG) Report

PR Newswire April 1, 2024

Azenta to Participate in the 23rd Annual Needham Virtual Healthcare Conference

PR Newswire April 1, 2024